Skip to main content
Log in

Atypical Kawasaki disease with peripheral gangrene and myocardial infarction: Therapeutic implications

  • Infectious Diseases
  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

We describe a 2-month-old girl with atypical Kawasaki disease (KD) complicated by peripheral gangrene and myocardial infarction. Peripheral ischaemia leading to gangrene is a rare but serious complication of KD in infants younger than 7 months of age. Treatment has been targeted at reducing arterial inflammation, arteriospasm and thrombosis. We report the first patient with incomplete KD and peripheral ischaemia in whom therapy with prostaglandin E1 (PGE1) as vasodilating and antithrombotic agent appeared successful, restoring hand and foot perfusion without significant long-term sequelae. However, PGE1 could have supported development of myocardial infarction by shunting blood away from ischaemic areas distal to a giant coronary artery aneurysm with beginning thrombosis.

Conclusion

Atypical KD with peripheral gangrene appears to react favourably to treatment with PGE1, but needs careful monitoring to detect early signs of cardiac ischaemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

IVGG :

intravenous gammaglobulin

KD :

Kawasaki disease

LAD :

left anterior descending

PGE1 :

prostaglandin E1

WBC :

white blood cells

References

  1. Ames EL, Jones JS, Van Dommelen B, Posch JL (1985) Bilateral hand necrosis in Kawasaki syndrome. J Hand Surg 10A: 391–395

    Google Scholar 

  2. Avner JR, Shaw KN, Chin AJ (1989) Atypical presentation of Kawasaki disease with early development of giant coronary artery aneurysms. J Pediatr 114: 605–606

    PubMed  Google Scholar 

  3. Boven K, DeGraeff-Meeder ER, Spliet W, Kuis W (1992) Atypical Kawasaki disease: an often missed diagnosis. Eur J Pediatr 151: 577–580

    PubMed  Google Scholar 

  4. Burns JC, Wiggins JW, Toews WH, Newburger JW, Leung DJM, Wilson II, Glodé MP (1986) Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109: 759–763

    PubMed  Google Scholar 

  5. Chusid MJ, Tang TT (1978) Fever, diarrhea, anemia, rash, and acrocyanosis in a 2-months-old girl. J Pediatr 93: 1052–1057

    PubMed  Google Scholar 

  6. Clifford PC, Martin MFR, Sheddon EJ, Kirby JD, Baird RN, Dieppe PA (1980) Treatment of vasospastic disease with prostaglandin E1. BMJ 281: 1031–1034

    PubMed  Google Scholar 

  7. Fiessinger JN, Schaefer M (1990) Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. Lancet 335: 555–557

    Article  PubMed  Google Scholar 

  8. Fujiwara H, Hamashima Y (1978) Pathology of the heart in Kawasaki disease. Pediatrics 61: 100–107

    PubMed  Google Scholar 

  9. Fukushige J, Nihill MR, McNamara DG (1980) Spectrum of cardiovascular lesions in mucocutaneous lymph node syndrome: Analysis of eight cases. Am J Cardiol 45: 98–107

    Article  PubMed  Google Scholar 

  10. Kato H, Ichinose E, Kawasaki T (1986) Myocardial infarction in Kawasaki disease: Clinical analysis in 195 cases. J Pediatr 108: 923–927

    PubMed  Google Scholar 

  11. Kawasaki T (1967) Acute febrile mucocutaneous lymph node syndrome: clinical observations of 50 cases. Jpn J Allergol 16: 178–222

    Google Scholar 

  12. Krapf R, Zimmermann A, Stocker F (1981) Lethal vasculitis of coronary arteries in a neonate and two infants: possible neonatal variant of the MLNS/IPN complex? Helv Paediatr Acta 36: 589–598

    PubMed  Google Scholar 

  13. Lancet editorial (1983) Prostaglandins and peripheral vascular disease. Lancet 1: 1199–1200

    Google Scholar 

  14. Nakamura Y, Fujita Y, Nagai M, Yanagawa H, Imada Y, Okawa S, Kawasaki T, Kato H (1991) Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Pediatrics 88: 1144–1447

    PubMed  Google Scholar 

  15. Nakano H, Saito A, Ueda K, Nojima K (1986) Clinical characteristics of myocardial infarction following Kawasaki disease: report of 11 cases. J Pediatr 108: 198–203

    PubMed  Google Scholar 

  16. Newburger JW, et al (1986) The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J Med 315: 341–347

    PubMed  Google Scholar 

  17. Newburger JW et al (1991) A single intravenous infusion of gammaglobulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324: 1633–1639

    PubMed  Google Scholar 

  18. Rowley AH, Shulman ST (1992) The clinical efficacy of IVGG in Kawasaki disease. Clin Rev Allergy 10: 81–91

    PubMed  Google Scholar 

  19. Teixeira OHP, Pong AH, Vlad P (1982) Amputating gangrene in Kawasaki disease. Can Med Assoc J 127: 132–134

    PubMed  Google Scholar 

  20. Tomita S, Chung K, Mas M, Gidding S, Shulman ST (1992) Peripheral gangrene associated with Kawasaki disease. Clin Infect Dis J 14: 121–126

    Google Scholar 

  21. Trumble T, Fitch RD (1986) Kawasaki disease — a cause of vasculitis in children. J Pediatr Orthop 6: 92–95

    PubMed  Google Scholar 

  22. Westphalen MA, McGrath Ma, Kelly W, Moore FJ, Ziegler JB (1988) Kawasaki disease with severe peripheral ischemia: treatment with prostaglandin E1 infusion. J Pediatr 112: 431–433

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

von Planta, M., Fasnacht, M., Holm, C. et al. Atypical Kawasaki disease with peripheral gangrene and myocardial infarction: Therapeutic implications. Eur J Pediatr 154, 830–834 (1995). https://doi.org/10.1007/BF01959792

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01959792

Key words

Navigation